Advertisement

Journal of Neural Transmission

, Volume 124, Issue 9, pp 1109–1121 | Cite as

Relationships between cognitive impairment on ADAS-cog and regional cerebral blood flow using SPECT in late-onset Alzheimer’s disease

  • Michio Takahashi
  • Yasunori Oda
  • Toshiyuki Okubo
  • Yukihiko ShirayamaEmail author
Neurology and Preclinical Neurological Studies - Original Article

Abstract

The aim of this study was to examine brain hypoperfusion and its relationship with cognitive dysfunction in late-onset Alzheimer’s disease (AD). Forty patients with late-onset AD and not receiving acetylcholinesterase inhibitors were recruited from outpatient clinics. We examined cognitive function using the Alzheimer’s Disease Assessment Scale-cognitive subscale (ADAS-cog) and brain perfusion using single-photon emission computed tomography, and analyzed classified gyrus level segments with three-dimensional stereotactic surface projection and the stereotactic extraction estimation method level 3. ADAS-cog subscales were grouped into three domains: language, memory, and praxis. Patients with late-onset AD showed an apparent reduction in regional cerebral blood flow (rCBF) with a z score >1.5 in the frontal, temporal, and limbic lobes, with lesser reduction in the parietal and occipital lobes. Although hypoperfusion in the orbital, rectal, and subcallosal gyri of the frontal lobe was prominent, rCBF in the inferior frontal gyrus of the frontal lobe was significantly correlated with ADAS-cog total and language and praxis subscale scores. The parahippocampal gyrus of the limbic lobe was also significantly correlated with the ADAS-cog total, language, and praxis subscale scores. Additionally, the cingulate of the limbic lobe was significantly related with ADAS-cog memory. In spite of lesser hypoperfusion, the posterior cingulate gyrus of the limbic lobe was significantly related with ADAS-cog total, language, and memory subscale scores. Further, each subdivision of ADAS-cog was found to be related with various brain regions.

Keywords

SPECT Late-onset Alzheimer’s disease ADAS rCBF 

Notes

Compliance with ethical standards

Funding

This research received no specific Grant from any funding agency or from commercial or not-for-profit sectors.

Conflict of interest

Dr. Shirayama has received research support from Eli Lilly, Eisai, MSD, Pfizer, and Mitsubishi-Tanabe. Dr. Okubo has received research support from Eisai, Bayer, and Daiichi Sankyo. Dr. Takahashi and Dr. Oda have no competing interests.

References

  1. American Psychiatric Association (1994) Diagnostic and statistic manual of mental disorders (DSN-IV-TR), 4th edn. American Psychiatric Press, Washington DC (text rev) Google Scholar
  2. Balsis S, Unger AA, Benge JF, Geraci L, Dooby RS (2012) Gaining precision on the Alzheimer’s Disease Assessment Scale-cognitive: a Comparison of item response theory-based scores and total scores. Alzheimer’s Dement 8:288–294CrossRefGoogle Scholar
  3. Bartenstein P, Minoshima S, Hirsch C, Buch K, Willoch F, Mösch D, Schad D, Schwaiger M, Kurz A (1997) Quantitative assessment of cerebral blood flow in patients with Alzheimer’s disease by SPECT. J Nucl Med 38:1095–1101PubMedGoogle Scholar
  4. Benge JF, Balsis S, Geraci L, Massman PJ, Doody RS (2009) How well do the ADAS-cog and its subscales measure cognitive dysfunction in Alzheimer’s disease? Dement Geriatr Cogn Disord 28:63–69CrossRefPubMedGoogle Scholar
  5. Cavedo E, Pievani M, Boccardi M, Galluzzi S, Bocchetta M, Bonetti M, Thompson PM, Frisoni GB (2014) Medial temporal atrophy in early and late-onset Alzheimer’s disease. Neurobiol Aging 35:2004–2012CrossRefPubMedPubMedCentralGoogle Scholar
  6. Dubois B, Feldman HH, Jacova C, Cummings JL, DeKosky ST, Barberger-Gateau P, Delacourte A, Frisoni G, Fox NC, Galasko D, Gauthier S, Hampel H, Jicha GA, Meguro K, O’Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Sarazin M, de Souza LC, Stern Y, Visser PJ, Scheltens P (2010) Revising the definition of Alzheimer’s disease: a new lexicon. Lancet Neurol 9:1118–1127CrossRefPubMedGoogle Scholar
  7. Elgh E, Sundström T, Näsman B, Åhlström KR, Nyberg L (2002) Memory functions and rCBF 99 mTc-HMPAO SPET: developing diagnostics in Alzheimer’s disease. Eur J Nucl Med 29:1140–1148CrossRefGoogle Scholar
  8. Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinicians. J Psychiatr Res 12:189–198CrossRefPubMedGoogle Scholar
  9. Frisoni GB, Pievani M, Testa C, Sabattoli F, Bresciani L, Bonetti M, Beltramello A, Hayashi KM, Toga AW, Thompson PM (2007) The topography of grey matter involvement in early and late onset Alzheimer’s disease. Brain 130:720–730CrossRefPubMedGoogle Scholar
  10. Frlich L, Eilles R, Ihl K, Maurer K, Lanczik M (1989) Stage-dependent reduction of regional cerebral blood flow measured by HMPAO-SPECT in dementia of Alzheimer type. Psychiatry Res 29:347–350CrossRefPubMedGoogle Scholar
  11. Grady CL, Haxby JV, Horwitz B, Berg G, Rapoport SI (1987) Neuropsychological and cerebral metabolic function in early vs late onset dementia of the Alzheimer type. Neuropsychologia 25:807–816CrossRefPubMedGoogle Scholar
  12. Hachinski VC, Iliff LD, Zilhka E, Du Boulay GH, McAllister VL, Marshall J, Russell RW, Symon L (1975) Cerebral blood flow in dementia. Arch Neurol 32:632–637CrossRefPubMedGoogle Scholar
  13. Hanaoka T, Kimura N, Aso Y, Takemaru M, Kimura Y, Ishibashi M, Matsubara E (2015) Relationship between white matter lesions and regional cerebral blood flow changes during longitudinal follow up in Alzheimer’s disease. Geriatr Gerontol Int 16:836–842CrossRefPubMedGoogle Scholar
  14. Hanyu H, Sato T, Hirao K, Kanetaka H, Iwamoto T, Koizumi K (2010) The progression of cognitive deterioration and regional cerebral blood flow patterns in Alzheimer’s disease: a longitudinal SPECT study. J Neurol Sci 290:96–101CrossRefPubMedGoogle Scholar
  15. Hirano N, Mori E, Ishii K, Ikejiri Y, Imamura T, Shimomura T, Hashimoto M, Yamashita H, Sasaki M (1998) Hypofunction in the posterior cingulate gyrus correlates with disorientation for time and place in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 64:552–554CrossRefGoogle Scholar
  16. Holman BL, Johnson KA, Gerada B, Carvalho PA, Satlin A (1992) The scintigraphic appearance of Alzheimer’s disease: a prospective study using technetium-99m-HMPAO SPECT. J Nucl Med 33:181–185PubMedGoogle Scholar
  17. Hongo J, Nakaaki S, Shinagawa Y, Murata Y, Sato J, Tatsumi H, Tohyama J, Soma T, Iidaka T, Fukui T, Mimura M, Furukawa T (2008) SPECT-identified neuroanatomical predictor of the cognitive effects of donepezil treatment in patients with Alzheimer’s disease. Dementia Geriatr Cog Disord 26:556–566CrossRefGoogle Scholar
  18. Imabayashi E, Matsuda H, Asada T, Ohnishi T, Sakamoto S, Nakano S, Inoue T (2004) Superiority of 3-dimensional stereotactic surface projection analysis over visual inspection in discrimination of patients with very early Alzheimer’s disease from controls using brain perfusion SPECT. J Nucl Med 45:1450–1457PubMedGoogle Scholar
  19. Ishii K, Willoch F, Minoshima S, Drzezga A, Ficaro EP, Cross DJ, Kuhl DE, Schwaiger M (2001) Statistical brain mapping of 18F-FDG PET in Alzheimer’s disease: validation of anatomic standardization for atrophied brains. J Nucl Med 42:548–557PubMedGoogle Scholar
  20. Ishii K, Kawachi T, Sasaki H, Kono AK, Fukuda T, Kojima Y, Mori E (2005) Voxel-based morphometric comparison between early- and late-onset mild Alzheimer’s disease and assessment of diagnostic performance of Z score images. Am J Neuroradiol 26:333–340PubMedGoogle Scholar
  21. Kaiser NC, Melrose RJ, Liu C, Sultzer DL, Jimenez E, Su M, Monserratt L, Mendez MF (2012) Neuropsychological and neuroimaging markers in early versus late-onset Alzheimer’s disease. Am J Alzheimers Dis Other Demen 27:520–529CrossRefPubMedPubMedCentralGoogle Scholar
  22. Kemp PM, Holmes C, Hoffmann SM, Bolt L, Holmes R, Rowden J, Fleming JS (2003) Alzheimer’s disease: differences in technetium-99m HMPAO SPECT scan findings between early onset and late onset dementia. J Neurol Neurosurg Psychiatry 74:715–719CrossRefPubMedPubMedCentralGoogle Scholar
  23. Kim EJ, Cho SS, Jeong Y, Park KC, Kang SJ, Kang E, Kim SE, Lee KH, Na DL (2005) Glucose metabolism in early onset versus late onset Alzheimer’s disease: an SPM analysis of 120 patients. Brain 128:1790–1801CrossRefPubMedGoogle Scholar
  24. Kuczynski B, Reed B, Mungas D, Weiner M, Chui HC, Jagust W (2008) Cognitive and anatomic contributions of metabolic decline in Alzheimer disease and cerebrovascular disease. Arch Neurol 65:650–655CrossRefPubMedPubMedCentralGoogle Scholar
  25. Kumar A, Schapiro MB, Grady C, Haxby JV, Wagner E, Salerno JA, Friedland RP, Rapoport SI (1991) High-resolution PET studies in Alzheimer’s disease. Neuropsychopharmacology 4:35–46PubMedGoogle Scholar
  26. Kume K, Hanyu H, Sato T, Hirao K, Shimizu S, Kanetaka H, Sakurai H, Iwamoto T (2011) Vascular risk factors are associated with faster decline of Alzheimer disease: a longitudinal SPECT study. J Neurol 258:1295–1303CrossRefPubMedGoogle Scholar
  27. Li W, Antuono PG, Xie C, Chen G, Jones JL, Ward BD, Franczak MB, Goveas JS, Li SJ (2012) Changes in regional cerebral blood flow and functional connectivity in the cholinergic pathway associated with cognitive performance in subjects with mild Alzheimer’s disease after 12-week donepezil treatment. Neuroimage 60:1083–1091CrossRefPubMedPubMedCentralGoogle Scholar
  28. McKeith IG, Bartholomew PH, Irvine EM, Cook J, Adams R, Simpson AE (1993) Single photon emission computerised tomography in elderly patients with Alzheimer’s disease and multi-infarct dementia. Regional uptake of technetium-labelled HMPAO related to clinical measurements. Br J Psychiatry 163:597–603CrossRefPubMedGoogle Scholar
  29. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology 34:939–944CrossRefPubMedGoogle Scholar
  30. Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE (1995) A diagnostic approach in Alzheimer’s disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 36:1238–1248PubMedGoogle Scholar
  31. Mizumura S, Kumita S, Cho K, Ishihara M, Nakajo H, Toba M, Kumazaki T (2003) Development of quantitative analysis method for stereotactic brain image: assessment of reduced accumulation in extent and severity using anatomical segmentation. Ann Nucl Med 17:289–295CrossRefPubMedGoogle Scholar
  32. Möller C, Vrenken H, Jiskoot L, Versteeg A, Barkhof F, Scheltens P, van der Flier WM (2013) Different patterns of gray matter atrophy in early-and late-onset Alzheimer’s disease. Neurobiol Aging 34:2014–2022CrossRefPubMedGoogle Scholar
  33. Montaldi D, Brooks DN, McColl JH, Wyper D, Patterson J, Barron E, McCulloch J (1990) Measurements of regional cerebral blood flow and cognitive performance in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 53:33–38CrossRefPubMedPubMedCentralGoogle Scholar
  34. Nobili F, Brugnolo A, Calvini P, Copello F, De Leo C, Girtler N, Morbelli S, Piccardo A, Vitali P, Rodriguez G (2005) Resting SPECT-neuropsychology correlation in very mild Alzheimer’s disease. Clin Neurophysiol 116:364–375CrossRefPubMedGoogle Scholar
  35. O’Brien JT, Eagger S, Syed GM, Sahakian BJ, Levy R (1992) A study of regional cerebral blood flow and cognitive performance in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 55:1182–1187CrossRefPubMedPubMedCentralGoogle Scholar
  36. Palasí A, Gutiérrez-Iglesias B, Alegret M, Pujadas F, Olabarrieta M, Liébana D, Quintana M, Álvarez-Sabín J, Boada M (2015) Differentiated clinical presentation of early and late-onset Alzheimer’s disease: is 65 years of age providing a reliable threshold? J Neurol 262:1238–1246CrossRefPubMedGoogle Scholar
  37. Reisberg B, Ferris SH, Anand R, de Leon MJ, Schneck MK, Buttinger C, Borenstein J (1984) Functional staging of dementia of the Alzheimer’s type. Ann NY Scad Sci 435:481–483CrossRefGoogle Scholar
  38. Rodriguez G, Morbelli S, Brugnolo A, Calvini P, Girtler N, Piccardo A, Dougall NJ, Ebmeier KP, Baron JC, Nobili F (2005) Global cognitive impairment should be taken into account in SPECT-neuropsychology correlations: the example of verbal memory in very mild Alzheimer’s disease. Eur J Nucl Med Mol Imag 32:1186–1192CrossRefGoogle Scholar
  39. Rosen WG, Mohs RC, Davis L (1984) A new rating scale for Alzheimer’s disease. Am J Psychiatry 141:1356–1364CrossRefPubMedGoogle Scholar
  40. Sá F, Pinto P, Cunha C, Lemos R, Letra L, Simões M, Santana I (2012) Differences between early and late-onset Alzheimer’s disease in neuropsychological tests. Front Neurol 14:81Google Scholar
  41. Sakamoto S, Ishii K, Sasaki M, Hosaka K, Mori T, Matsui M, Hirano N, Mori E (2002) Differences in cerebral metabolic impairment between early and late onset types of Alzheimer’s disease. J Neurol Sci 200:27–32CrossRefPubMedGoogle Scholar
  42. Smits LL, Pijnenburg YA, Koedam EL, van der Vlies AE, Reuling IE, Koene T, Teunissen CE, Scheltens P, van der Flier WM (2012) Early onset Alzheimer’s disease is associated with a distinct neuropsychological profile. J Alzheimers Dis 30:101–108PubMedGoogle Scholar
  43. Song I, Chung Y, Chung S, Jeong J (2014) Early diagnosis of Alzheimer’s disease and Parkinson’s disease associated with dementia using cerebral perfusion SPECT. Dement Geriatr Cogn Disord 37:276–285CrossRefPubMedGoogle Scholar
  44. Tippett WJ, Black SE (2008) Regional cerebral blood flow correlates of visuospatial tasks in Alzheimer’s disease. J Int Neuropsychol Soc 14:1034–1045CrossRefPubMedGoogle Scholar
  45. Verma N, Beretvas SN, Pascual B, Masdeu JC, Markey MK (2015) The Alzheimer’s disease neuroimaging initiative. New scoring methodology improves the sensitivity of the Alzheimer’s Disease Assessment Scale-Cognitive subscale (ADAS-Cog) in clinical trials. Alzheimers Res Ther 7:64CrossRefPubMedPubMedCentralGoogle Scholar
  46. Waldemar G, Bruhn P, Kristensen M, Johnson A, Paulson OB, Lassen NA (1994) Heterogeneity of neocortical cerebral blood flow deficits in dementia of the Alzheimer type: a [99Tc]-d, l-HMPAO SPECT study. J Neuro Neurosurg Psychiatry 57:285–295CrossRefGoogle Scholar
  47. Yamashita K, Taniwaki Y, Utsunomiya H, Taniwaki T (2014) Cerebral blood flow reduction associated with orientation for time in amnesic mild cognitive impairment and Alzheimer disease patients. J Neuroimaging 24:590–594CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Wien 2017

Authors and Affiliations

  • Michio Takahashi
    • 1
  • Yasunori Oda
    • 3
  • Toshiyuki Okubo
    • 2
  • Yukihiko Shirayama
    • 1
    Email author
  1. 1.Department of PsychiatryTeikyo University Chiba Medical CenterIchiharaJapan
  2. 2.Department of RadiologyTeikyo University Chiba Medical CenterIchiharaJapan
  3. 3.Department of PsychiatryChiba University Graduate School of MedicineChibaJapan

Personalised recommendations